The Patent Finder

Sciclone Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Sciclone Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Sciclone Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,207,294Treatment of Aspergillus infections with alpha thymosin peptides
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,716,012Alpha thymosin peptides as vaccine enhancers
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 9,724,395Treatment of cancer with immune stimulators
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 11,571,465Treatment of cancer with alpha thymosin peptide and PD-1 inhibitors
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,017,129Use of thymosin alpha 1 for preparing a medicament for the treatment of stage IV malignant melanoma
Formerly held
Term ended
Term ended Jun 15, 2026 · USPTO record
Term endedTerm ended Jun 15, 2026USPTO record
US 8,389,680Treatment of Aspergillus infections with alpha thymosin peptides
Formerly held
Term ended
Ended no later than Mar 29, 2024 · USPTO record
Term endedEnded no later than Mar 29, 2024USPTO record
US 7,297,676Thymosin alpha 1 peptide/polymer conjugates
Formerly held
Term ended
Term ended Nov 1, 2022 · USPTO record
Term endedTerm ended Nov 1, 2022USPTO record
US 7,208,167Treatment of hepatitis C with thymosin and peptide combination therapy
Formerly held
Term ended
Term ended Nov 7, 2021 · USPTO record
Term endedTerm ended Nov 7, 2021USPTO record
US 8,193,152Treatment or prevention of hemorrhagic viral infections with immunomodulator compounds
Formerly held
Lapsed on the fee record
Ended Jun 5, 2020 · USPTO record
Lapsed on the fee recordEnded Jun 5, 2020USPTO record
US 6,462,017Method of reducing side effects of chemotherapy in cancer patients
Formerly held
Term ended
Term ended May 1, 2020 · USPTO record
Term endedTerm ended May 1, 2020USPTO record
10 of 33 patents shown.
Pro members see all 33.
Pro members: see all 33 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited